#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dent's disease Anti-HLA antibody test positive Cutaneous calcification ROHHAD syndrome Chordoma Juvenile idiopathic arthritis Renal cancer metastatic Ischaemic stroke Diffuse large B-cell lymphoma recurrent Hyperchylomicronaemia Hypocalcaemia Soft tissue necrosis Thyroid cancer metastatic T-cell lymphoma Acute myeloid leukaemia (in remission) More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Diagnostics Leiomyosarcoma – Diagnostics Rhabdoid tumour – Treatment Toxic epidermal necrolysis Medulloblastoma recurrent – Trials in Disease Usher’s syndrome – Life with Disease Ornithine transcarbamoylase deficiency – Basic Information Nephrotic syndrome – Life with Disease Loeys-Dietz syndrome – Basic Information Bronchiolitis obliterans syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Recombinant Interferon Beta-1B Sodium Chloride Ph. Eur. ANERATRIGINE MESILATE Bnt314 Zimberelimab Magnesium Sulfate Tub-040 Piperacillin Soya-Bean Oil Refined Masitinib Efinopegdutide Solifenacin Succinate [18F] CANAGLIFLOZIN Bay 3283142 Tasimelteon Rezpegaldesleukin Lovotibeglogene Autotemcel Atogepant Collagenase Sodium Phosphate More therapies…

    Learn about Your Condition

    Leiomyosarcoma Asplenia Hyperparathyroidism primary Lichen planopilaris Testis cancer Graft versus host disease Kearns-Sayre syndrome Factor IX deficiency Liposarcoma Short stature Pericarditis Hairy cell leukaemia Eclampsia Prader-Willi syndrome Vasospasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pouchitis

  • Study of guselkumab and dietary changes for patients with recurring or difficult-to-treat pouchitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Guselkumab
    Belgium

  • Study on GM-CSF, Fosfomycin, and Metronidazole for Treating Pouchitis in Ulcerative Colitis Patients Post-Surgery

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Fosfomycin
    • Metronidazole
    • Molgramostim
    Denmark

  • Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Rifamycin Sodium
    • Vedolizumab
    • Amoxicillin Sodium
    Belgium Croatia Czechia Denmark Greece Italy +2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!